Log in

Dolby Laboratories Stock Forecast, Price & News

-0.99 (-1.50 %)
(As of 09/23/2020 12:00 AM ET)
Today's Range
Now: $64.90
50-Day Range
MA: $68.30
52-Week Range
Now: $64.90
Volume1.01 million shs
Average Volume444,580 shs
Market Capitalization$6.53 billion
P/E Ratio26.82
Dividend Yield1.34%
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications; Dolby TrueHD, a digital audio coding technology providing encoding for Blu-ray discs and home theaters; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Read More
Dolby Laboratories logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 2.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.03 out of 5 stars

Industry, Sector and Symbol

Industry Patent owners & lessors
Sub-IndustryElectronic Components



Sales & Book Value

Annual Sales$1.24 billion
Cash Flow$3.37 per share
Book Value$23.10 per share


Net Income$255.15 million


Market Cap$6.53 billion
Next Earnings Date11/12/2020 (Estimated)
-0.99 (-1.50 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DLB News and Ratings via Email

Sign-up to receive the latest news and ratings for DLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Dolby Laboratories (NYSE:DLB) Frequently Asked Questions

How has Dolby Laboratories' stock been impacted by Coronavirus (COVID-19)?

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DLB shares have increased by 7.8% and is now trading at $64.90.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Dolby Laboratories?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Dolby Laboratories

When is Dolby Laboratories' next earnings date?

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Dolby Laboratories

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories, Inc. (NYSE:DLB) announced its earnings results on Monday, August, 3rd. The electronics maker reported $0.86 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.13 by $0.73. The electronics maker earned $246.91 million during the quarter, compared to analyst estimates of $232.61 million. Dolby Laboratories had a net margin of 20.89% and a return on equity of 10.67%. Dolby Laboratories's revenue for the quarter was down 18.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 earnings per share.
View Dolby Laboratories' earnings history

How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?

Dolby Laboratories announced a quarterly dividend on Tuesday, August 4th. Investors of record on Monday, August 17th will be paid a dividend of $0.22 per share on Wednesday, August 26th. This represents a $0.88 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Friday, August 14th.
View Dolby Laboratories' dividend history

What guidance has Dolby Laboratories issued on next quarter's earnings?

Dolby Laboratories updated its fourth quarter earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.22-0.37 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.42. The company issued revenue guidance of $225-255 million, compared to the consensus revenue estimate of $251.94 million.

What price target have analysts set for DLB?

5 brokers have issued 1 year price targets for Dolby Laboratories' stock. Their forecasts range from $65.00 to $83.00. On average, they expect Dolby Laboratories' share price to reach $73.67 in the next year. This suggests a possible upside of 13.5% from the stock's current price.
View analysts' price targets for Dolby Laboratories

Who are some of Dolby Laboratories' key competitors?

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Vishay Intertechnology (VSH) and Rogers (ROG).
View all competitors

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital Wireless (IDCC), Advanced Micro Devices (AMD), Energy Transfer LP Unit (ET), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), Stag Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Who are Dolby Laboratories' key executives?

Dolby Laboratories' management team includes the following people:
  • Mr. Kevin J. Yeaman, Pres, CEO & Director (Age 53)
  • Mr. Lewis Chew, Principal Financial Officer (Age 56)
  • Mr. Andy Sherman, Exec. VP, Gen. Counsel & Corp. Sec. (Age 52)
  • Mr. Todd Pendleton, Sr. VP & Chief Marketing Officer (Age 47)
  • Mr. Giles Baker, Sr. VP of Consumer Entertainment (Age 43)

What is Dolby Laboratories' stock symbol?

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.86%), Ceredex Value Advisors LLC (1.25%), Bank of New York Mellon Corp (1.12%), Bank of Montreal Can (0.96%), Nantahala Capital Management LLC (0.92%) and Blair William & Co. IL (0.86%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories

Which institutional investors are selling Dolby Laboratories stock?

DLB stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Thrivent Financial for Lutherans, First Trust Advisors LP, Nuveen Asset Management LLC, Canada Pension Plan Investment Board, Bank of America Corp DE, Vanguard Group Inc., and Bank of Montreal Can. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories

Which institutional investors are buying Dolby Laboratories stock?

DLB stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Kayne Anderson Rudnick Investment Management LLC, Alyeska Investment Group L.P., KAMES CAPITAL plc, Marathon Asset Management LLP, Ceredex Value Advisors LLC, Obermeyer Wood Investment Counsel Lllp, and Seizert Capital Partners LLC.
View insider buying and selling activity for Dolby Laboratories

How do I buy shares of Dolby Laboratories?

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dolby Laboratories' stock price today?

One share of DLB stock can currently be purchased for approximately $64.90.

How big of a company is Dolby Laboratories?

Dolby Laboratories has a market capitalization of $6.53 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.

What is Dolby Laboratories' official website?

The official website for Dolby Laboratories is www.dolby.com.

How can I contact Dolby Laboratories?

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.